Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | RECQL | P46063 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | PKM | P14618 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9822039 | 0.83 | RECQL (0.33) | TDP1RECQLALDH1A1HTTPKM | |
| SCHEMBL9821928 | 0.81 | RECQL (0.50) | RECQLALDH1A1HTT | |
| SCHEMBL9822121 | 0.81 | RECQL (0.33) | RECQLALDH1A1HTT | |
| SCHEMBL9822160 | 0.79 | ALDH1A1 (0.34) | RECQLALDH1A1HTT | |
| SCHEMBL9821985 | 0.78 | RECQL (0.37) | RECQLALDH1A1HTT | |
| SCHEMBL9822152 | 0.76 | TDP1 (0.46) | TDP1ALDH1A1PKM | |
| SCHEMBL9822234 | 0.75 | HCAR2 (0.39) | TDP1RECQLALDH1A1HTTPKM | |
| SCHEMBL9822276 | 0.74 | — | — | |
| SCHEMBL9822487 | 0.74 | KDM4E (0.35) | RECQLALDH1A1HTT | |
| SCHEMBL9821991 | 0.73 | TDP1 (0.38) | TDP1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4987129-A | BACTERICIDES | SANKEI PHARMACEUTICAL CO., LTD. (JP) | 1991-01-22 | — | — | US | disclosed |
| US-4958019-A | Intermediates for synthesis of cephalosporin compounds | SANKEI PHARMACEUTICAL CO., LTD. (JP) | 1990-09-18 | — | — | US | disclosed |
| US-4956462-A | Bactericides, ANTIBIOTICS, CEPHALOSPORINS | SANKEI PHARMACEUTICAL CO., LTD. (JP) | 1990-09-11 | — | — | US | disclosed |
| EP-0302633-A2 | Beta-lactam compound, process for preparing the same, intermediate for synthesis of the same and medicinal composition for bacterially infectious disease therapy containing the same | SANKEI PHARMACEUTICAL COMPANY LIMITED (JP) | 1989-02-08 | — | — | EP | disclosed |